FDA Grants Fast Track Designation for AJ201 for Kenndy`s Disease
23 Oct 2025 //
PR NEWSWIRE
Annji Showcases Clinical Breakthrough Of AJ201 At WMS 2025
13 Oct 2025 //
PR NEWSWIRE
AnnJi Pharma Reports Positive Phase 1/2a results for AJ20
21 May 2025 //
PR NEWSWIRE
AnnJi Pharma inks deal worth $250 M for muscular atrophy treatment
14 Mar 2023 //
BIOSPECTRUM ASIA
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics
10 Mar 2023 //
PR NEWSWIRE

Market Place
Sourcing Support